Studies on the NFkB activation via diacylglycerol kinase alpha
| Project/Area Number |
20570135
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Functional biochemistry
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
KAI Masahiro Sapporo Medical University, 医学部, 講師 (80260777)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAKANE Fumio 札幌医科大学, 医学部, 准教授 (10183815)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | NFκB / アポトーシス / ジアシルグリセロールキナーゼ / メラノーマ / プロテインキナーゼC / 大腸がん / NFкB |
|---|
| Research Abstract |
Using human melanoma cells, we demonstrated that diacylglycerol kinase (DGK) alpha enhanced tumor necrosis factor-alpha (TNF-alpha)-induced activation of nuclear factor-kappaB (NF-kappaB) via protein kinase Czeta-dependent phosphorylation of a large subunit of NF-kappaB, p65/RelA. We found that the both of DGKalpha-specfic siRNA and TNF-alpha significantly attenuated the melanoma tumor growth in mice. DGKalpha is suggested to be a novel therapeutic target for melanoma.
|
Report
(4 results)
Research Products
(25 results)
